Gypenoside LXXV

Gypenoside LXXV, isolated from Gynostemma pentaphyllum, is one of the deglycosylated shapes of ginsenoside Rb1. Gypenoside LXXV significantly reduces cancer cell viability and displays an anti-cancer effect[1].

Product Specifications

CAS Number

[110261-98-8]

UNSPSC

12352005

Target

Others

Type

Natural Products

Related Pathways

Others

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/gypenoside-lxxv.html

Purity

98.83

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

C[C@@]([C@@]([C@@]1([H])[C@@]2([H])[C@@](CC/C=C(C)/C)(C)O[C@@H]([C@@H]([C@H]3O)O)O[C@@H]([C@H]3O)CO[C@@H]([C@@H]([C@H]4O)O)O[C@@H]([C@H]4O)CO)(CC2)C)(CC[C@@]5([H])C6(C)C)[C@@](C[C@H]1O)([H])[C@]5(CC[C@@H]6O)C

Molecular Formula

C42H72O13

Molecular Weight

785.01

References & Citations

[1]Chang-Hao Cui, et al. Enhanced Production of Gypenoside LXXV Using a Novel Ginsenoside-Transforming β-Glucosidase from Ginseng-Cultivating Soil Bacteria and Its Anti-Cancer Property. Molecules. 2017 May 19;22 (5) :844.